Edition:
United States

Cumberland Pharmaceuticals Inc (CPIX.OQ)

CPIX.OQ on NASDAQ Stock Exchange Global Select Market

7.20USD
14 Dec 2017
Change (% chg)

$0.02 (+0.28%)
Prev Close
$7.18
Open
$7.39
Day's High
$7.44
Day's Low
$7.15
Volume
2,628
Avg. Vol
3,021
52-wk High
$7.95
52-wk Low
$5.30

Chart for

About

Cumberland Pharmaceuticals Inc. (Cumberland) is a specialty pharmaceutical company. The Company is focused on the acquisition, development and commercialization of branded prescription products. The Company operates through specialty pharmaceutical products segment. The Company's product portfolio includes Acetadote (acetylcyste... (more)

Overall

Beta: 0.86
Market Cap(Mil.): $112.13
Shares Outstanding(Mil.): 15.75
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 32.50 16.04
EPS (TTM): -- -- --
ROI: -- 15.11 35.70
ROE: -- 16.59 15.40

BRIEF-Cumberland Pharmaceuticals Inc files for mixed shelf of up to $100 million

* Cumberland Pharmaceuticals Inc files for mixed shelf of up to $100 million Source text: (http://bit.ly/2jazuqV) Further company coverage:

Nov 07 2017

BRIEF-Cumberland Pharmaceutical reports Q3 loss per share $0.05

* Cumberland Pharmaceutical reports 27% revenue growth in the third quarter

Nov 07 2017

BRIEF-Cumberland Pharmaceuticals launches promotion of Totect in U.S. for emergency oncology intervention

* Cumberland Pharmaceuticals launches promotion of Totect® in the U.S. for emergency oncology intervention

Sep 25 2017

BRIEF-Cumberland Pharmaceuticals Q2 adjusted loss per share $0.05

* Cumberland Pharmaceutical reports double digit revenue growth for the fourth consecutive quarter

Aug 08 2017

BRIEF-Cumberland Pharmaceuticals begin U.S. shipments of dexrazoxane for oncology patient support

* Cumberland Pharmaceuticals begin U.S. shipments of dexrazoxane for oncology patient support

Jul 31 2017

Earnings vs. Estimates